Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BioArctic | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 15.29B | -84.8x | 0.46 | SEK 174 | 4.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cereno Scientific | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 2.02B | -20.4x | 0.25 | SEK 7.16 | 3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BioInvent International | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.78B | -4.1x | 0.14 | SEK 27.15 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Intellego Technologies AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.61B | 13.7x | 1.57 | SEK 59 | 7.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vicore Pharma Holding AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.53B | -5.3x | -0.14 | SEK 6.54 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Devyser Diagnostics AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.51B | -24.2x | 1.77 | SEK 91.50 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hansa Biopharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.43B | -1.6x | -0.1 | SEK 21.12 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Egetis Therapeutics AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.29B | -3.2x | -0.29 | SEK 3.58 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
XSpray Pharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.19B | -3.8x | 0.14 | SEK 32.15 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nanoform Finland Plc | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.06B | -3.7x | 0.64 | SEK 12.14 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SynAct Pharma AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 932.15M | -9.5x | -0.17 | SEK 19.06 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.7% Upside | Upgrade to Pro+ | |
Saniona AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 882.25M | 3.7x | 0.02 | SEK 6.55 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Diamyd Medical | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 797.32M | -4.5x | 0.23 | SEK 7.69 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hamlet Pharma AB | Spotlight | Healthcare | Biotechnology & Medical Research | SEK 765.82M | -16.9x | 1.18 | SEK 4.31 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nykode Therapeutics | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 711.28M | -1.9x | SEK 13.98 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Promimic AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 470.42M | -36.7x | 1.09 | SEK 24 | -3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oncopeptides | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 444.74M | -1.2x | -0.04 | SEK 1.96 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.1% Upside | Upgrade to Pro+ | |
Cantargia AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 380.38M | -1.7x | -0.04 | SEK 1.53 | 8.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Peptonic Medical | Spotlight | Healthcare | Biotechnology & Medical Research | SEK 345.56M | -0.01 | SEK 0.004 | -32.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Initiator Pharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 338.07M | -17.5x | -0.37 | SEK 6.02 | -4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Intervacc | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 323.77M | -0.9x | -0.11 | SEK 0.94 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Xbrane Biopharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 306.44M | -0.9x | -0.01 | SEK 0.20 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ascelia Pharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 281.11M | -1.9x | -0.06 | SEK 3.01 | 2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Mendus AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 252.81M | -1.9x | -0.05 | SEK 5.02 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Guard Therapeutics | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 244.03M | -1.4x | -0.11 | SEK 12.10 | -9.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Xintela | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 233.03M | -5.1x | -0.13 | SEK 0.35 | -7.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medivir B | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 206.39M | -1.9x | -0.04 | SEK 1.85 | 43.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AlzeCure Pharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 193.37M | -4.8x | -0.26 | SEK 2.30 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Glycorex Transplantation | NGM | Healthcare | Biotechnology & Medical Research | SEK 184.52M | -15.6x | -0.24 | SEK 2.34 | 9.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Curasight AS | Spotlight | Healthcare | Biotechnology & Medical Research | SEK 172.72M | -4.8x | 0.09 | SEK 7.50 | -8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Alzinova | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 167.63M | -6.1x | -0.33 | SEK 1.90 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Annexin Pharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 165.76M | -2.8x | -0.05 | SEK 0.31 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Klaria Pharma Holding AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 156.34M | -2.8x | 0.55 | SEK 1.08 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SenzaGen | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 142.50M | -7.2x | -0.25 | SEK 4.83 | 2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kancera AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 141.55M | -3.1x | -0.06 | SEK 1.21 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.2% Upside | Upgrade to Pro+ | |
AroCell | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 124.39M | -3x | -0.11 | SEK 0.54 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Coegin Pharma AB | NGM | Healthcare | Biotechnology & Medical Research | SEK 111.95M | -3.4x | -0.08 | SEK 4.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lumito AB | NGM | Healthcare | Biotechnology & Medical Research | SEK 110.61M | -2.7x | 0.06 | SEK 0.42 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bio-Works | Spotlight | Healthcare | Biotechnology & Medical Research | SEK 107.97M | -1.7x | -0.05 | SEK 1.38 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Alligator Bioscience | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 102.79M | -0x | -0.01 | SEK 6.08 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abera Bioscience | Spotlight | Healthcare | Biotechnology & Medical Research | SEK 92.88M | -81.7x | -0.8 | SEK 5.85 | -3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 37.2% Upside | Upgrade to Pro+ | |
Active Biotech | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 88.57M | -0.8x | -0.05 | SEK 0.07 | 4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Spago Nanomedical AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 75.91M | -2x | -0.03 | SEK 0.22 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dextech Medical | Spotlight | Healthcare | Biotechnology & Medical Research | SEK 75.79M | -15.8x | 5.93 | SEK 4.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biovica International | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 72.36M | -0.6x | -0.01 | SEK 0.72 | -8.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biosergen AS | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 70.45M | -5.3x | -0.04 | SEK 0.31 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NextCell Pharma AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 68.63M | -3.7x | -0.06 | SEK 0.81 | -13.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Acousort | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 54.81M | -3.5x | -0.17 | SEK 3.67 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Combigene | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 47.52M | -1.1x | 0.04 | SEK 2.40 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Modus Therapeutics Holding AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 45.82M | -3.1x | -0.05 | SEK 1.26 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -5.5% Downside | Upgrade to Pro+ |